Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Development of New Generation of Vaccines for Brucella Abortus Publisher



Gheibi A1 ; Khanahmad H2 ; Kashfi K3 ; Sarmadi M2 ; Khorramizadeh MR4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Molecular, Cellular and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medicine, New York, United States
  4. 4. Biosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Heliyon Published:2018


Abstract

Brucella abortus is a Gram-negative facultative and intracellular bacteria, it causes bovine brucellosis, a zoonotic disease that is responsible for considerable economic loss to owners of domesticated animals and can cause problems in otherwise healthy humans. There are a few available live attenuated vaccines for animal immunization against brucellosis; however, these have significant side effects and offer insufficient protective efficacy. Thus, the need for more research into the Molecular pathobiology and immunological properties of B. abortus that would lead to the development of better and safer vaccines. In this paper we have reviewed the main aspects of the pathology and the responsive immunological mechanisms, we have also covered current and new prospective vaccines against B. abortus. © 2018
Related Docs
1. Design and Characterization of a Recombinant Brucella Abortus Rb51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response, Vaccines (2022)
2. Simultaneous Immunization of Mice With Omp31 and Tf Provides Protection Against Brucella Melitensis Infection, Vaccine (2015)
3. Intraperitoneal Immunization With Urease Loaded N-Trimethyl Chitosan Nanoparticles Elicits High Protection Against Brucella Melitensis and Brucella Abortus Infections, Immunology Letters (2018)
4. Preparation of a Nanovaccine Against Brucella Melitensis M16 Based on Plga Nanoparticles and Oligopolysaccharide Antigen, Artificial Cells# Nanomedicine and Biotechnology (2019)
5. A New Elisa Kit Based on Antigenic Epitopes for Diagnosing Brucella Abortus, Korean Journal of Microbiology and Biotechnology (2019)
6. Molecular Investigation of Virulence Factors of Brucella Melitensis and Brucella Abortus Strains Isolated From Clinical and Non-Clinical Samples, Microbial Pathogenesis (2017)
Experts (# of related papers)
View all Related Experts
Mohammad Reza Khorramizadeh (1)
Mehdi Shafee Ardestani (1)